Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of the following products to be supplied as sub-packs: Pabrinex Intramuscular High Potency solution for injection 5ml and 2ml – 20 ampoule 10 x (5ml amps + 2ml amps) Pabrinex Intravenous High Potency solution for injection 5ml [...]
The post Pabrinex reclassified as special container appeared first on PSNC Website.
Pharmacy contractors should note a number of changes that have been made to different SSPs. SSP Extensions SSP029 for Sandrena® 0.5mg and 1mg gel sachets – restriction has been extended to 28 February 2023. It was previously set to expire on 27 January 2023. SSP030 for Sandrena® 0.5mg and 1mg gel sachets – substitution has been extended [...]
The post Further SSP updates appeared first on PSNC Website.
The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]
The post Drug Tariff Watch – February 2023 appeared first on PSNC Website.
The Department of Health and Social Care (DHSC) has today (26/01/2023) granted the following list of price concessions for January 2023. Drug Pack Size Price concession Amoxicillin 125mg/5ml oral suspension 100 £5.01 Brimonidine 0.2% eye drops 5 £4.60 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £12.53 Cefalexin 250mg tablets 28 £3.25 Clarithromycin 250mg/5ml oral [...]
The post January 2023 Price Concessions 3rd Update appeared first on PSNC Website.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 6 January 2023) has been published and includes articles on: Xaqua (metolazone) 5mg tablets: exercise caution when switching patients between metolazone preparations Topical testosterone (Testogel): risk of harm to children following accidental exposure Electronic Prescribing and Medicines Administration Systems: report [...]
The post MHRA Drug Safety Update January 2023 appeared first on PSNC Website.
Recent Comments